Assessment of Iron Deficiency in Cyanotic Congenital Heart Diseases

Key Points

• The aim is to evaluate the prevalence and impact of iron deficiency in patients with cyanotic congenital heart diseases.
• The study involves a cohort of patients diagnosed with cyanotic congenital heart diseases.
• Iron status was assessed using serum ferritin and hemoglobin levels.
• Participants received treatment with ferrous sulfate for iron deficiency.
• A significant percentage of patients exhibited iron deficiency (specific prevalence rates not provided).
• Post-treatment, hemoglobin levels improved in patients treated with ferrous sulfate (exact metrics not listed).
• The relation between iron deficiency and increased morbidity in cyanotic congenital heart patients was established.